Karl Sanford, Vice President Technology Development at Genencor (a Danisco Division) will give a presentation on “Enzymes, Pathways and the Future” at the Future of Bio-Based Chemicals: From Inception to Marketplace conference to be held this year in San Francisco, CA on September 13-14, 2010 by GTCbio.
Genencor develops and sells enzymes for a number of industrial market segments. The customers in these segments are increasingly interested in sustainable solutions for their needs thus providing a significant market pull. Karl’s presentation will address the growing opportunity for product development in industrial biotechnology and will profile bio-catalysts with a view of how they can shape the future and how collaborations and partnerships facilitate commercialization
